Sid Mathur

Sid Mathur

Company: Merck & Co

Job title: Executive Director, Regulatory Affairs & Companion Diagnostics


Understanding the Current Regulations Underpinning Clinical Trials Harnessing CDx Tests for Clearer Guidelines on the Tests 1:50 pm

Providing clarification on the regulatory status of CDx assays in clinical trials Shifting attention to the regulations pertaining tests run in clinical trials – why is it important What are some approaches used for biomarker testing in clinical trials and how do they pave the way for market accessRead more

day: Day 2 Track C PM

Panel Discussion: Driving Actionable Steps Towards Clinical Trial Diversity Through Harnessing Equity, Diversity & Inclusion (ED&I) to Ensure Precision Medicine is a Fit-for-All 10:10 am

Addressing the under-representation of the world’s population in genomic datasets available to pharmaceutical companies and clinicians Illustrating the importance of implementing ED&I in CDx design to facilitate more accurate clinical decisions  Establishing regulatory frameworks and guidelines to advocate for the wide-spread ED&I in biomarker discovery, clinical biomarker development and CDx development and ensure precision medicine…Read more

day: Day 1 AM 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.